Clinical Trial Update: Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating psilocybin alone and psilocybin-assisted cognitive behavioral therapy for major depressive disorder; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Khyber Medical University Peshawar | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED